Literature DB >> 1916156

Albumin mRNA expression in human liver diseases and its correlation to serum albumin concentration.

I Ozaki1, M Motomura, Y Setoguchi, N Fujio, K Yamamoto, T Kariya, T Sakai.   

Abstract

The expression of albumin mRNA in human liver samples was investigated in order to understand the molecular mechanism of albumin gene expression in various liver diseases. Albumin mRNA in acute hepatic failure and decompensated liver cirrhosis was reduced significantly compared to normal control liver (P less than 0.05). Serum albumin concentration is closely correlated with albumin mRNA content (r = 0.895, P less than 0.01). These data suggest that albumin concentration is mainly regulated at albumin mRNA level in the liver despite the presence of other regulatory mechanisms and that expression of albumin mRNA level is correlated with disease severity. But in several cases there was a discrepancy between albumin mRNA level and severity of liver disease, so further investigation of the regulatory factors of albumin gene expression should be performed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1916156     DOI: 10.1007/bf02782816

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  22 in total

1.  Determination of protein spots separated by two-dimensional polyacrylamide gel electrophoresis.

Authors:  S Matsuhashi; T Mukai; K Hori
Journal:  J Chromatogr       Date:  1985-01-25

2.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

3.  Different mechanisms decrease hepatic collagen and albumin production in fasted rats.

Authors:  M Chojkier; M Flaherty; B Peterkofsky; G H Majmudar; R G Spanheimer; D A Brenner
Journal:  Hepatology       Date:  1988 Sep-Oct       Impact factor: 17.425

4.  Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia.

Authors:  D A Brenner; M Buck; S P Feitelberg; M Chojkier
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

5.  Molecular mechanisms for changes in hepatic protein synthesis induced by schistosomiasis infection in mice.

Authors:  M A Zern; M A Saber; D A Shafritz
Journal:  Biochemistry       Date:  1983-12-20       Impact factor: 3.162

6.  Augmentation of albumin but not fibrinogen synthesis by corticosteroids in patients with hepatocellular disease.

Authors:  G D Cain; G Mayer; E A Jones
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

7.  Development of molecular hybridization technology to evaluate albumin and procollagen mRNA content in baboons and man.

Authors:  F R Weiner; M J Czaja; M A Giambrone; C H Wu; G Y Wu; M A Zern
Journal:  Hepatology       Date:  1987 Jan-Feb       Impact factor: 17.425

8.  Changes in albumin, alpha-fetoprotein and collagen gene transcription in CCl4-induced hepatic fibrosis.

Authors:  A Panduro; F Shalaby; L Biempica; D A Shafritz
Journal:  Hepatology       Date:  1988 Mar-Apr       Impact factor: 17.425

9.  Regulation of synthesis and secretion of major rat acute-phase proteins by recombinant human interleukin-6 (BSF-2/IL-6) in hepatocyte primary cultures.

Authors:  T Andus; T Geiger; T Hirano; T Kishimoto; T A Tran-Thi; K Decker; P C Heinrich
Journal:  Eur J Biochem       Date:  1988-04-15

10.  Nucleotide sequence and the encoded amino acids of human serum albumin mRNA.

Authors:  A Dugaiczyk; S W Law; O E Dennison
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

View more
  7 in total

Review 1.  The clinical use of albumin: the point of view of a specialist in intensive care.

Authors:  Pietro Caironi; Luciano Gattinoni
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

2.  Alteration of micronutrient status in compensated and decompensated liver cirrhosis.

Authors:  Kaushik Kar; Anindya Dasgupta; M Vijaya Bhaskar; K Sudhakar
Journal:  Indian J Clin Biochem       Date:  2013-06-14

3.  Expression of albumin, IGF-1, IGFBP-3 in tumor tissues and adjacent non-tumor tissues of hepatocellular carcinoma patients with cirrhosis.

Authors:  Shi-Min Luo; Wei-Min Tan; Wei-Xiong Deng; Si-Min Zhuang; Jian-Wei Luo
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

4.  Substrate stiffness regulates primary hepatocyte functions.

Authors:  Vaishaali Natarajan; Eric J Berglund; Dorothy X Chen; Srivatsan Kidambi
Journal:  RSC Adv       Date:  2015-09-14       Impact factor: 3.361

5.  Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis.

Authors:  Shi-Min Luo; Li-Jian Liang; Jia-Ming Lai
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

6.  Influence of surface topography on PCL electrospun scaffolds for liver tissue engineering.

Authors:  Yunxi Gao; Anthony Callanan
Journal:  J Mater Chem B       Date:  2021-10-06       Impact factor: 6.331

7.  Bone marrow derived-mesenchymal stem cells downregulate IL17A dependent IL6/STAT3 signaling pathway in CCl4-induced rat liver fibrosis.

Authors:  Shimaa Farouk; Salwa Sabet; Fatma A Abu Zahra; Akmal A El-Ghor
Journal:  PLoS One       Date:  2018-10-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.